featured
The End-of-the-Road for Immunotherapies in GBM or New Opportunities for More Nuanced/aggressive Approaches? CheckMate 498
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: